On the case of 35 old patient with steroid-resistant nephrotic syndrome in the course of membranoproliferative glomerulonephritis complicated with renal failure, we paid the attention to the therapeutic efficacy of CsA in this case with remission of nephrotic syndrome and significant improvement of renal function, which enabled us to withdraw the patient from the hemodialysis programme.